By Editor

I’ve always been fascinated by space… I grew up on Dune, 2001: A Space Odyssey, and (pre-Disney) Star Wars. The prospect of humanity exploring the stars, deploying satellites, and potentially…

Search Stock Profiles

Latest News

REGN: Regeneron Pharmaceuticals – Buy or Sell This Biotech Brainiac?

Regeneron Pharmaceuticals (REGN) is the biotech jungle’s clever monkey, swinging at $730.30 (U.S. News) with a…

By Editor

VRTX: Vertex Pharmaceuticals – Buy or Sell This Biotech Beast?

Vertex Pharmaceuticals (VRTX) is the biotech jungle’s roaring lion, lounging at $485.58 (StockAnalysis.com) with a market…

By Editor

My Top 3 Stocks in Healthcare AI and Digital Health

AI is shaking up healthcare — cutting costs, speeding diagnoses, and transforming entire fields. From virtual…

By Editor

Why Palantir (PLTR) Has Been Soaring — And What Traders Can Learn From It

Why Palantir (PLTR) Has Been Soaring — And What Traders Can Learn From ItPalantir (PLTR)’s earnings…

By Editor

How Retail Investors Outplayed Wall Street in April

Retail investors crushed it in April 2025 — buying when hedge funds bailed and turning the…

By Editor

The Auction Heard ‘Round Wall Street

Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt the ground shift beneath…

By Editor

AMGN: Amgen – Buy or Sell This Biotech Bruiser?

Amgen (AMGN) is the biotech jungle’s hulking gorilla, stomping at $283.50 (TipRanks) with a $100 billion+ market cap as of…

By Editor
2 Min Read

The Biotech Bonanza: A Wild Ride Through the Stock Market Jungle

Buckle up, folks, because the biotech stock market as of March 26, 2025, is a jungle gym of thrills, spills,…

By Editor
7 Min Read

ABNB: Airbnb Stock – Buy or Sell This Travel Trailblazer?

Airbnb (ABNB) is the travel renegade crashing couches at $128.80 (StockAnalysis.com) as of March 26, 2025. It’s the cool kid…

By Editor
2 Min Read